New Biologics for Asthma
- PMID: 29782236
- DOI: 10.1056/NEJMe1806037
New Biologics for Asthma
Comment on
-
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21. N Engl J Med. 2018. PMID: 29782217 Clinical Trial.
-
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.N Engl J Med. 2018 Jun 28;378(26):2475-2485. doi: 10.1056/NEJMoa1804093. Epub 2018 May 21. N Engl J Med. 2018. PMID: 29782224 Clinical Trial.
Similar articles
-
New Biologics for Severe Asthma: What Patients, What Agents, What Results, at What Cost?Am J Respir Crit Care Med. 2019 Feb 15;199(4):406-408. doi: 10.1164/rccm.201810-1974ED. Am J Respir Crit Care Med. 2019. PMID: 30407843 No abstract available.
-
[THE EFFECTS OF LAMA ON ASTHMA AND THE THERAPY OF BIOLOGICAL AGENTS IN SEVERE ASTHMA].Arerugi. 2019;68(8):904-910. doi: 10.15036/arerugi.68.904. Arerugi. 2019. PMID: 31534099 Japanese. No abstract available.
-
Drug Development and Biologics in Asthma. A New Era.Ann Am Thorac Soc. 2016 Mar;13 Suppl 1:S83-4. doi: 10.1513/AnnalsATS.201509-573MG. Ann Am Thorac Soc. 2016. PMID: 27027958 Review.
-
Indirect treatment comparison of asthma biologics fraught with methodology issues.J Allergy Clin Immunol. 2019 Mar;143(3):1266-1267. doi: 10.1016/j.jaci.2018.11.024. Epub 2019 Jan 11. J Allergy Clin Immunol. 2019. PMID: 30639069 No abstract available.
-
Biologic and New Therapies in Asthma.Immunol Allergy Clin North Am. 2017 May;37(2):329-343. doi: 10.1016/j.iac.2017.01.007. Immunol Allergy Clin North Am. 2017. PMID: 28366480 Review.
Cited by
-
The Saudi initiative for asthma - 2024 update: Guidelines for the diagnosis and management of asthma in adults and children.Ann Thorac Med. 2024 Jan-Mar;19(1):1-55. doi: 10.4103/atm.atm_248_23. Epub 2023 Dec 15. Ann Thorac Med. 2024. PMID: 38444991 Free PMC article.
-
Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.Respir Res. 2023 Dec 6;24(1):305. doi: 10.1186/s12931-023-02620-1. Respir Res. 2023. PMID: 38057814 Free PMC article.
-
Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases.Pharmaceutics. 2023 Aug 17;15(8):2151. doi: 10.3390/pharmaceutics15082151. Pharmaceutics. 2023. PMID: 37631365 Free PMC article. Review.
-
Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation.J Allergy Clin Immunol. 2023 May;151(5):1269-1276. doi: 10.1016/j.jaci.2023.01.020. Epub 2023 Feb 3. J Allergy Clin Immunol. 2023. PMID: 36740144 Free PMC article. Clinical Trial.
-
The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children.Ann Thorac Med. 2021 Jan-Mar;16(1):4-56. doi: 10.4103/atm.ATM_697_20. Epub 2021 Jan 14. Ann Thorac Med. 2021. PMID: 33680125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical